Kidney Disease, ChronicTEACH-PDNCT03816111
Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial
A study testing TEACH-PD Training Curriculum and Current standard PD training in people with Kidney Disease, Chronic and Peritoneal Dialysis Catheter-Associated Peritonitis, run by The University of Queensland at 48 sites in 2 countries.
Trial summary
For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Kidney Disease, Chronic, Peritoneal Dialysis Catheter-Associated Peritonitis, Peritoneal Dialysis Catheter Exit Site Infection
- What is being tested?
- TEACH-PD Training Curriculum and Current standard PD training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,462 participants
- Where
- 48 sitesin 2 countries
- Study dates
- 22 Jul 2019to 30 Apr 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients new to PD;
- Patients > 18 years of age,
- Need to undergo PD training;
- Are able to provide informed consent
Who cannot join
None listed.
Trial locations and contacts
48 sites in 2 countries.
48 sites in 2 countries
Australia33 sites
Royal Adelaide Hospital
Adelaide, South Australia
Princess Alexandra Hospital
Brisbane, Queensland
Cairns Hospital
Cairns, Queensland
Canberra Hospital
Canberra, Australian Capital Territory
Monash Health
Dandenong, Victoria
St Vincent's Hospital Sydney
Darlinghurst, New South Wales, 2010
Royal Darwin Hospital
Darwin, Northern Territory, 0810
St Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065
Barwon Health
Geelong, Victoria, 3220
Gosford Hospital
Gosford, New South Wales
Austin Health
Heidelberg, Victoria
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029
Royal Hobart Hospital
Hobart, Tasmania, 7000
Launceston General Hospital
Launceston, Tasmania, 7250
Lismore Hospital
Lismore, New South Wales
Mackay Base Hospital
Mackay, Queensland, 4740
Logan Hospital
Meadowbrook, Queensland
Royal Melbourne Hospital
Melbourne, Victoria
Fiona Stanley Hospital
Murdoch, Western Australia, 6150
Sunshine Coast University Hospital
Nambour, Queensland
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009
Orange Hospital
Orange, New South Wales
Royal Perth Hospital
Perth, Western Australia, 6000
Gold Coast University Hospital
Southport, Queensland
Royal North Shore Hospital
St Leonards, New South Wales
Liverpool Hospital
Sydney, New South Wales
Nepean/Blacktown Hospital
Sydney, New South Wales
Prince of Wales Hospital
Sydney, New South Wales
Royal Prince Alfred/Concord Hospital
Sydney, New South Wales
St George Hospital
Sydney, New South Wales
Tamworth Hospital
Tamworth, New South Wales
Toowoomba Hospital
Toowoomba, Queensland
The Tweed Hospital
Tweed Heads, New South Wales, 2485
New Zealand15 sites
Waitakere Hospital
Auckland, 0610
North Shore Hospital
Auckland, 0620
Auckland Hospital
Auckland
Middlemore Hospital
Auckland
Wairau Hospital
Blenheim, 7201
Christchurch Hospital
Christchurch
Dunedin Hospital
Dunedin
Gisborne Hospital
Gisborne, 4010
Waikato Hospital
Hamilton, 3204
Hawke's Bay Hospital
Hastings
Nelson Hospital
Nelson, 7010
Taranaki Hospital
New Plymouth
Palmerston North/Whanganui Hospital
Palmerston North
Wellington Hospital
Wellington, 6021
Whangarei Hospital
Whangarei
About this study
Official title: A Pragmatic, Registry-based, International, Cluster-randomized Controlled Trial Examining the Use of TEACH-PD Training Modules for Incident PD Patients Versus Existing Practices on the Rate of PD-related Infections
For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. The best way to prevent PD related infections is to make sure that patients have good training in PD techniques. The researchers of this study have developed TEACH-PD, a new education package for training both PD nurses and PD patients.
The aim of this study is to find out whether TEACH-PD training reduces the number of PD related infections.
Read the detailed description
End stage kidney disease is fatal unless treated with dialysis or transplant. Peritoneal dialysis (PD) is a core dialysis modality offering home-based care for patients. PD utilization is frequently threatened beyond 5 years for most patients due to PD-related infections. Patient training is a critical cornerstone of mitigating infection risk and maximizing PD durability (technique survival), but training practices are characterized by a lack of standardization and severe heterogeneity.
There is no high-level evidence to inform PD training. Accordingly, a structured program encompassing how and what to teach PD patients at the inception of PD treatment has the potential to reduce serious PD-related infections, extend the longevity of PD, support cost-effective home-based dialysis care, and reduce costs and health service utilization associated with hospitalization and transition to haemodialysis. TEACH-PD is a standardised modular curriculum for both PD nurse trainers and patients that has been collaboratively developed by renal nurses, doctors, educationalists and patients, aligned to current International Society for Peritoneal Dialysis (ISPD) guidelines, utilizing modern adult learning principles. The TEACH-PD program is feasible and acceptable, as demonstrated in a successful pilot study.
The primary objective of TEACH-PD CRCT (Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - a Cluster Randomised Controlled Trial) is to determine whether implementation of standardised training modules based on ISPD guidelines targeting both PD trainers and patients results in a longer time to the composite end-point of exit site infections, tunnel infections and peritonitis in incident PD patients compared to existing training practices.
TEACH-PD is a registry-based, pragmatic, multi-center, multinational trial, randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices.
An estimated 1,500 patient new to PD will be recruited from at least approximately 42-44 PD units in Australia and New Zealand.The study is being coordinated by the University of Queensland (operating through the Australasian Kidney Trial Network).
The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilizing modern adult learning principles and best practice eLearning techniques. The modules will be implemented at PD units in Australia and New Zealand to formally evaluate whether, compared with standard care, a standardised training curriculum will reduce the rate of PD-related infections and improve technique survival, resulting in better outcomes for patients receiving PD and significant cost-savings to the community.
- Conditions
- Kidney Disease, Chronic, Peritoneal Dialysis Catheter-Associated Peritonitis, Peritoneal Dialysis Catheter Exit Site Infection, Peritoneal Dialysis Catheter Tunnel Infection
- Being tested
- TEACH-PD Training Curriculum, Current standard PD training
- Keywords
- Training
- Medical subject headings
- Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TEACH-PD Training CurriculumBehavioural
The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the International Society for Peritoneal Dialysis guidelines, utilizing modern adult learning principles and best practice eLearning techniques.
Current standard PD trainingBehavioural
Current PD training materials and plan
| Study group | Role | What they receive |
|---|---|---|
| TEACH-PD Training Curriculum | Experimental | All patients at sites randomized to this arm will receive the TEACH-PD Training Curriculum Receives: Behavioral: TEACH-PD Training Curriculum |
| Current Standard PD Training | Active comparator | All patients at sites randomized to this arm will receive the unit's current PD training materials and plan Receives: Behavioral: Current standard PD training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to the first occurrence of any PD-related infection
Time to the first occurrence of any PD-related infection including exit site infection, tunnel infection or peritonitis
Measured: From the PD start date until first PD-related infection, assessed up to 4 years
Secondary outcomes (10)
Time to first exit site infection
Time to first exit site infection
Measured: From the PD start date until first exit site infection, assessed up to 4 years
Time to first tunnel infection
Time to first tunnel infection
Measured: From the PD start date until first tunnel infection, assessed up to 4 years
Time to first episode of peritonitis
Time to first episode of peritonitis
Measured: From the PD start date until first peritonitis episode, assessed up to 4 years
Time to infection-associated catheter removal
Time to infection-associated catheter removal
Measured: From the PD start date until first infection-associated catheter removal, assessed up to 4 years
Incidence of technique failure - 30 days
Incidence of technique failure defined as transfer to haemodialysis for greater than 30-days and/or death within this time
Measured: Assessed at 30 days after transfer to HD or if death occurs within this period
Incidence of technique failure - 180 days
Incidence of technique failure defined as transfer to haemodialysis for greater than 180-days and/or death within this time
Measured: Assessed at 180 days after transfer to HD or if death occurs within this period
Incidence of all-cause hospitalization
Incidence of all-cause hospitalization collected via health department hospitalization data linkage
Measured: Assessed from the PD start date, over up to 4 years
Incidence of all-cause mortality
Incidence of all-cause mortality
Measured: Assessed from the PD start date, over up to 4 years
Participant Quality of Life questionnaire
Participant-reported Quality of Life measured using EQ-5D-5L (EuroQol-5 dimensions questionnaire). EQ-5D-5L measures quality of life using 2 methods - a descriptive scale and a Visual Analogue Scale. The descriptive scale comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/ depression). Each dimension has 5 measurement levels: no problems (1), slight problems (2), moderate problems (3), severe problems (4), and extreme problems (5). Numbers associated with levels can be used to report an index score.
The VAS records the respondent's self-rated health on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' (100) and 'the worst health you can imagine' (0).
Measured: Completed at baseline, 6, 12, 18 and 24 months
Health-care cost-effectiveness analysis
Difference in the incremental cost per Quality Adjusted Life Years gained between treatment arms
Measured: Assessed from the PD start date, over up to 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jan 2019
- Study start22 Jul 2019
- Primary completion31 Mar 2025
- Study completion30 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Kidney Disease, ChronicStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,462 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Queensland
- Sponsor type
- University, hospital or other
- Collaborators
- The HOME Network, Australia and New Zealand Dialysis and Transplant Registry, New Zealand Peritoneal Dialysis Registry
- Responsible party
- Sponsor
- Investigators
- Neil C Boudville, Prof, Study chair, University of Western Australia & Sir Charles Gairdner HospitalJosephine S Chow, Prof, Study chair, South Western Sydney Local Health DistrictYeoungjee Cho, PhD, Study director, Queensland Health/Princess Alexandra Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03816111
- Sponsor's protocol ID
- AKTN 17.03
- Acronym
- TEACH-PD
- Status last verified
- Mar 2026
- First submitted
- 12 Dec 2018
- Last updated
- 31 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data that underlie the results reported in the primary publication, after deidentification (text, tables, figures and appendices) will be available for individual participant data meta-analysis.
Publications
Chow JS, Boudville N, Green S, Cho Y, Mihala G, Kasza J, Campbell R, Candler H, Hawley CM, Hickey LE, Kiriwandeniya C, Matsuyama M, Movva R, Pascoe EM, Reidlinger DM, Valks A, Velayudham P, Vergara L, Armstrong C, Buisman B, Equinox KL, Figueiredo AE, Fuge T, Haselden R, Hayat A, Howard K, Howell M, Jaure A, Jose MD, Lee A, San Miguel S, Moodie JA, Nguyen TT, Saweirs WW, Steiner-Lim GZ, Tomlins M, Upjohn M, Voss D, Walker RC, Johnson DW; Collaborative Authors. Standardised training for reducing peritoneal dialysis-related infection: a cluster randomised controlled study. EClinicalMedicine. 2026 Jul 23;98:104089. doi: 10.1016/j.eclinm.2026.104089. eCollection 2026 Aug.
PubMed 42542615Chow JSF; TEACH-PD Investigators. Baseline characteristics of the TEACH-PD trial participants compared with the contemporary Australian and New Zealand PD patient population: a multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections. BMC Nephrol. 2026 Feb 20;27(1):194. doi: 10.1186/s12882-025-04440-5.
PubMed 41721291Chow JSF, Boudville N, Cho Y, Palmer S, Pascoe EM, Hawley CM, Reidlinger DM, Hickey LE, Stastny R, Valks A, Vergara L, Movva R, Kiriwandeniya C, Candler H, Mihala G, Buisman B, Equinox KL, Figueiredo AE, Fuge T, Howard K, Howell M, Jaure A, Jose MD, Lee A, Miguel SS, Moodie JA, Nguyen TT, Pinlac G, Reynolds A, Saweirs WWM, Steiner-Lim GZ, TeWhare B, Tomlins M, Upjohn M, Voss D, Walker RC, Wilson J, Johnson DW. Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol. Trials. 2023 Nov 14;24(1):730. doi: 10.1186/s13063-023-07715-0.
PubMed 37964367
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pragmatic, Registry-based, International, Cluster-randomized Controlled Trial Examining the Use of TEACH-PD Training Modules for Incident PD Patients Versus Existing Practices on the Rate of PD-related Infections
- ClinicalTrials.gov ID
- NCT03816111
- Acronym / sponsor ID
- TEACH-PD / AKTN 17.03
- Conditions
- Kidney Disease, Chronic, Peritoneal Dialysis Catheter-Associated Peritonitis, Peritoneal Dialysis Catheter Exit Site Infection, Peritoneal Dialysis Catheter Tunnel Infection
- Keywords
- Training
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,462 participants (actual)
- Lead sponsor
- The University of QueenslandUniversity, hospital or other
- Collaborators
- The HOME Network, Australia and New Zealand Dialysis and Transplant Registry, New Zealand Peritoneal Dialysis Registry
- Study start
- 22 Jul 2019 (actual)
- Primary completion
- 31 Mar 2025 (actual)
- Study completion
- 30 Apr 2025 (actual)
- First posted
- 25 Jan 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. The best way to prevent PD related infections is to make sure that patients have good training in PD techniques. The researchers of this study have developed TEACH-PD, a new education package for training both PD nurses and PD patients.
The aim of this study is to find out whether TEACH-PD training reduces the number of PD related infections.
Detailed description
End stage kidney disease is fatal unless treated with dialysis or transplant. Peritoneal dialysis (PD) is a core dialysis modality offering home-based care for patients. PD utilization is frequently threatened beyond 5 years for most patients due to PD-related infections. Patient training is a critical cornerstone of mitigating infection risk and maximizing PD durability (technique survival), but training practices are characterized by a lack of standardization and severe heterogeneity.
There is no high-level evidence to inform PD training. Accordingly, a structured program encompassing how and what to teach PD patients at the inception of PD treatment has the potential to reduce serious PD-related infections, extend the longevity of PD, support cost-effective home-based dialysis care, and reduce costs and health service utilization associated with hospitalization and transition to haemodialysis. TEACH-PD is a standardised modular curriculum for both PD nurse trainers and patients that has been collaboratively developed by renal nurses, doctors, educationalists and patients, aligned to current International Society for Peritoneal Dialysis (ISPD) guidelines, utilizing modern adult learning principles. The TEACH-PD program is feasible and acceptable, as demonstrated in a successful pilot study.
The primary objective of TEACH-PD CRCT (Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - a Cluster Randomised Controlled Trial) is to determine whether implementation of standardised training modules based on ISPD guidelines targeting both PD trainers and patients results in a longer time to the composite end-point of exit site infections, tunnel infections and peritonitis in incident PD patients compared to existing training practices.
TEACH-PD is a registry-based, pragmatic, multi-center, multinational trial, randomising PD units to implementing TEACH-PD training modules targeted at PD trainers and incident PD patients versus standard existing practices.
An estimated 1,500 patient new to PD will be recruited from at least approximately 42-44 PD units in Australia and New Zealand.The study is being coordinated by the University of Queensland (operating through the Australasian Kidney Trial Network).
The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the ISPD guidelines, utilizing modern adult learning principles and best practice eLearning techniques. The modules will be implemented at PD units in Australia and New Zealand to formally evaluate whether, compared with standard care, a standardised training curriculum will reduce the rate of PD-related infections and improve technique survival, resulting in better outcomes for patients receiving PD and significant cost-savings to the community.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| TEACH-PD Training Curriculum | Experimental | Behavioral: TEACH-PD Training CurriculumAll patients at sites randomized to this arm will receive the TEACH-PD Training Curriculum |
| Current Standard PD Training | Active comparator | Behavioral: Current standard PD trainingAll patients at sites randomized to this arm will receive the unit's current PD training materials and plan |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Patients new to PD;
- Patients > 18 years of age,
- Need to undergo PD training;
- Are able to provide informed consent
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TEACH-PD Training CurriculumThe TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the International Society for Peritoneal Dialysis guidelines, utilizing modern adult learning principles and best practice eLearning techniques. | Behavioural | TEACH-PD Training Curriculum |
| Current standard PD trainingCurrent PD training materials and plan | Behavioural | Current Standard PD Training |
Primary outcome
Time to the first occurrence of any PD-related infection
Time frame: From the PD start date until first PD-related infection, assessed up to 4 years
Time to the first occurrence of any PD-related infection including exit site infection, tunnel infection or peritonitis
10 secondary outcomes
Time to first exit site infection
Time frame: From the PD start date until first exit site infection, assessed up to 4 years
Time to first tunnel infection
Time frame: From the PD start date until first tunnel infection, assessed up to 4 years
Time to first episode of peritonitis
Time frame: From the PD start date until first peritonitis episode, assessed up to 4 years
Time to infection-associated catheter removal
Time frame: From the PD start date until first infection-associated catheter removal, assessed up to 4 years
Incidence of technique failure - 30 days
Time frame: Assessed at 30 days after transfer to HD or if death occurs within this period
Incidence of technique failure - 180 days
Time frame: Assessed at 180 days after transfer to HD or if death occurs within this period
Incidence of all-cause hospitalization
Time frame: Assessed from the PD start date, over up to 4 years
Incidence of all-cause mortality
Time frame: Assessed from the PD start date, over up to 4 years
Participant Quality of Life questionnaire
Time frame: Completed at baseline, 6, 12, 18 and 24 months
Health-care cost-effectiveness analysis
Time frame: Assessed from the PD start date, over up to 4 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2026.
- Derived from this study: PubMed 42542615Chow JS, Boudville N, Green S, Cho Y, Mihala G, Kasza J, Campbell R, Candler H, Hawley CM, Hickey LE, Kiriwandeniya C, Matsuyama M, Movva R, Pascoe EM, Reidlinger DM, Valks A, Velayudham P, Vergara L, Armstrong C, Buisman B, Equinox KL, Figueiredo AE, Fuge T, Haselden R, Hayat A, Howard K, Howell M, Jaure A, Jose MD, Lee A, San Miguel S, Moodie JA, Nguyen TT, Saweirs WW, Steiner-Lim GZ, Tomlins M, Upjohn M, Voss D, Walker RC, Johnson DW; Collaborative Authors. Standardised training for reducing peritoneal dialysis-related infection: a cluster randomised controlled study. EClinicalMedicine. 2026 Jul 23;98:104089. doi: 10.1016/j.eclinm.2026.104089. eCollection 2026 Aug.
- Derived from this study: PubMed 41721291Chow JSF; TEACH-PD Investigators. Baseline characteristics of the TEACH-PD trial participants compared with the contemporary Australian and New Zealand PD patient population: a multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections. BMC Nephrol. 2026 Feb 20;27(1):194. doi: 10.1186/s12882-025-04440-5.
- Derived from this study: PubMed 37964367Chow JSF, Boudville N, Cho Y, Palmer S, Pascoe EM, Hawley CM, Reidlinger DM, Hickey LE, Stastny R, Valks A, Vergara L, Movva R, Kiriwandeniya C, Candler H, Mihala G, Buisman B, Equinox KL, Figueiredo AE, Fuge T, Howard K, Howell M, Jaure A, Jose MD, Lee A, Miguel SS, Moodie JA, Nguyen TT, Pinlac G, Reynolds A, Saweirs WWM, Steiner-Lim GZ, TeWhare B, Tomlins M, Upjohn M, Voss D, Walker RC, Wilson J, Johnson DW. Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol. Trials. 2023 Nov 14;24(1):730. doi: 10.1186/s13063-023-07715-0.
- Individual participant dataSharing planned: Yes. Individual participant data that underlie the results reported in the primary publication, after deidentification (text, tables, figures and appendices) will be available for individual participant data meta-analysis.
Related trials for Kidney Disease, Chronic
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
RecruitingPhase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Berger Disease, Bergers Disease
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Not yet recruiting
An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care
Chronic Kidney Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Neil C Boudville, Prof study chair
University of Western Australia & Sir Charles Gairdner Hospital
Josephine S Chow, Prof study chair
South Western Sydney Local Health District
Yeoungjee Cho, PhD study director
Queensland Health/Princess Alexandra Hospital
48 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TEACH-PD Training Curriculum and Current standard PD training in people with Kidney Disease, Chronic and Peritoneal Dialysis Catheter-Associated Peritonitis, run by The University of Queensland at 48 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 48 sites in Australia, New Zealand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to the first occurrence of any PD-related infection (time frame: From the PD start date until first PD-related infection, assessed up to 4 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03816111, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2026.